Skip to content

Author

J. Larrañaga-Moreira

We have 4 of 60 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.

BACKGROUND Hypertrophic cardiomyopathy (HCM) is a heritable trait with marked variability in expression and outcomes. Our aims were to discover new genetic loci associated with HCM and to test the effect of a new polygenic risk score (PRS) on incidence, phenotype and outcomes stratified by genotype status. METHODS A...

Luis R. Lopes, Nay Aung, S. van Duijvenboden et al. · 0 citations
Oct 2026

Adverse Remodeling and Fibrosis Predict Outcomes in Excessive Trabeculation of the Left Ventricle: A Multiparametric CMR Risk Score.

BACKGROUND Excessive trabeculation of the left ventricle (ETLV) is a heterogeneous and controversial phenotype that overlaps with both physiological remodeling and cardiomyopathy. OBJECTIVES This study sought to develop and validate a cardiac magnetic resonance (CMR)-based model to predict major adverse cardiovascula...

Guillem Casas, E. Ródenas-Alesina, Javier Limeres et al. · 0 citations
Sep 2026

Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy.

These findings support MVA multiparametric prediction over the traditional left ventricular ejection fraction ≤35% threshold and allow clinically meaningful arrhythmic risk classification in patients with nonischemic dilated cardiomyopathy.

Noemí Ramos-López, N. Mora-Ayestarán, Juan Pablo Ochoa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.